Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2026-01-25 @ 7:30 AM
Study NCT ID:
NCT00490568
Status:
TERMINATED
Last Update Posted:
2017-11-13
First Post:
2007-06-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-08-08
Start Date Type:
ACTUAL
Primary Completion Date:
2009-06-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-06-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-21
First Submit QC Date:
None
Study First Post Date:
2007-06-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-09-05
Results First Submit QC Date:
None
Results First Post Date:
2017-11-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-05-03
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-10-11
Last Update Post Date:
2017-11-13
Last Update Post Date Type:
ACTUAL